Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Food and Drug Administration

FDA rejects Moderna’s mRNA flu vaccine application - for reasons with no basis in the law

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine.

The Conversation

House lawmaker raises new concerns over FDA's ultra-fast drug review program

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs

The Independent UK

7 Things That Will Get Cheaper After Budget 2026

Most budgets promise relief. Very few actually change what you pay in real life. Budget 2026 is one of those rare ones that works quietly. There were no dramatic tax cuts, no loud announcements, and no instant price drops flashed across screens. Yet, beneath the fine print, the government made…

Times Life

From analysis to the latest developments in health,
read the most diverse news in one place.

Legal questions swirl around FDA's new expedited drug program, including who should sign off

A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been rocked by recent layoffs and resignations

The Independent UK

A 74 year-old woman distributed 150,000 doses of fentanyl in the mail in ‘side hustle’ to pay for her meds

The elderly woman sent more than 1,000 parcels suspected to have contained illegal drugs, with a raid on her Austin home uncovering 18,000 pills

The Independent UK

FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access

The Food and Drug Administration is seeking to drastically change procedures for testing vaccine safety and approving vaccines, based on unproven claims that mRNA-based COVID-19 vaccines caused the death of at least 10 children.

The Conversation

FDA drug chief signals possible exit as agency turmoil deepens

Richard Pazdur’s potential retirement weeks into the role adds to upheaval at the FDA amid political pressure

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules

The Food and Drug Administration’s top vaccine regulator is pushing new limits on how vaccines win approval. The tougher standards could cloud prospects for vaccine makers and rattle investors in major healthcare and biotech names.

Benzinga

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Shares of Heartbeam Inc (NASDAQ:BEAT) rose sharply in pre-market trading after announcing its regulatory strategy following the Food and Drug Administration’s Not Substantially Equivalent (NSE) decision on its 12-lead Electrocardiogram Synthesis Software.

Benzinga

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

The Food and Drug Administration announced on Thursday the first round of experimental drugs to be included in a priority voucher program. This FDA initiative is designed to expedite drug review processes for products that align with critical U.S. national health priorities, reducing review times from 10 to 12 months…

Benzinga

FDA Adds New Warning For Johnson & Johnson's Cancer Cell Therapy

The Food and Drug Administration (FDA) has updated safety labeling for Johnson Johnson's (NYSE:JNJ) Carvykti after receiving reports of immune effector cell-associated enterocolitis (IEC-EC)—a rare but serious complication seen in both clinical trials and postmarketing data.

Benzinga

FDA Expands Use Of Regeneron's Evkeeza To Infants With Rare Cholesterol Disorder

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals, Inc.’s (NASDAQ: REGN) Evkeeza (evinacumab-dgnb) ANGPTL3 antibody as an adjunct to diet and exercise and other lipid-lowering therapies for the treatment of children from age 1 to less than 5 years old with homozygous familial hypercholesterolemia (HoFH).

Benzinga

Ousted FDA vaccine chief Vinay Prasad is returning to the agency

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top vaccine regulator

The Independent UK

Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue

The Food and Drug Administration (FDA) said on Wednesday it is monitoring a potential safety issue involving Boston Scientific Corporation’s (NYSE:BSX) ENDOTAK RELIANCE defibrillation leads, following a letter from the company alerting healthcare providers of possible reduced shock efficacy.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

FDA Sounds Alarm On Nationwide Butter Recall: Upgrades Risk Over Allergen Warning

The Food and Drug Administration has heightened concerns over a nationwide butter recall, escalating the risk level after discovering the presence of an undeclared major allergen.

Benzinga

Celsius Energy Drink Cans Mislabeled With Vodka Triggers Recall And FDA Warning: What's Going On?

An unspecified number of cans labeled as Celsius Holdings Inc. (NASDAQ:CELH) energy drinks were accidentally filled with High Noon vodka seltzer before reaching stores, prompting a recall posted to the Food and Drug Administration's website.

Benzinga

Congress Sounds Alarm Over Illegal Weight-Loss Drug Imports From China

In a letter to the U.S. Food and Drug Administration (FDA) Commissioner Marty Makary on Friday, over 80 bipartisan members asked the agency to stop counterfeit and copycat versions of GLP-1 drugs like Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide) and Eli Lilly and Co.’s (NYSE:LLY) Zepbound from flooding the market.

Benzinga

GSK's Blood Cancer Drug Review Extended As FDA Seeks More Data

The US Food and Drug Administration (FDA) on Wednesday extended the review period for the Biologics License Application (BLA) for GSK plc’s (NYSE:GSK) Blenrep combinations for relapsed or refractory multiple myeloma patients who have received at least one prior line of therapy.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Does Australia really take too long to approve medicines, as the US says?

Australia’s drug approval system is under fire, with critics in the United States claiming it is too slow to approve life-saving medicines.

The Conversation

‘Gas station heroin’: the drug sold as a dietary supplement that’s linked to overdoses and deaths

The US Food and Drug Administration (FDA) has issued an urgent warning about tianeptine – a substance marketed as a dietary supplement but known on the street as “gas station heroin”.

The Independent UK

Disposable e-cigarettes are more toxic than traditional cigarettes, researchers say

Lead and other harmful metals linked to cancer were found in disposable e-cigarettes

The Conversation

US approves twice-yearly injection for HIV prevention – what you need to know about lenacapavir

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new treatment marks a major advancement in expanding prevention options for people at risk of HIV infection.

The Independent UK

Supreme court widens court options for vaping companies pushing back against FDA rules

The Supreme Court is siding with e-cigarette companies in a ruling that'll make it easier to sue over Food and Drug Administration decisions blocking their products from the multibillion-dollar vaping market

The Independent UK

FDA to offer faster drug reviews to companies promoting 'national priorities'

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health

The Independent UK

Kraft Heinz pulling certain artificial dyes from its US products in 2027

Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the dyes

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.